Literature DB >> 22415947

Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011.

Matthias Oelke1, Ruth Kirschner-Hermanns, Nikesh Thiruchelvam, John Heesakkers.   

Abstract

AIMS: This ICI-RS report aims to analyze morphological or functional complications of the lower or upper urinary tract in elderly men, clarify the association between complications and benign prostatic obstruction (BPO) and define men who will develop these complications. Research proposals to further enlighten these associations were to be defined.
METHODS: A think-tank discussion was held on the annual ICI-RS meeting in 2011. The published literature between 1966 and 2011 was reviewed and research proposals were defined with all congress participants.
RESULTS: Post-void residual, bladder diverticula or calculi, vesico-ureteral reflux, hydronephrosis, renal insufficiency, and urinary retention appear with greater prevalence in patients with symptoms or signs of benign prostatic hyperplasia. BPO may directly or indirectly be responsible for these complications but conclusive evidence for BPO as the primary cause does not exist. Many of the complications have a multifactorial etiology and BPO is only partially responsible. It is currently impossible to define men who will develop complications.
CONCLUSIONS: In contrast to the widespread belief of urologist, there is only rudimentary data available showing no convincing association between urinary tract complications and BPO. The ICI-RS proposes that prospective trials are conducted to demonstrate the association between complications and BPO by using cystometry, pressure-flow (P/F) studies, and other commonly used BPO parameters in men with complications and comparing those with a cohort of age-matched men without complications. Non-invasive proxy parameters of BPO, for example, ultrasonic measurement of detrusor wall thickness, can be used instead of P/F studies especially in longitudinal trials.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22415947     DOI: 10.1002/nau.22222

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  14 in total

1.  Vesicoureteral reflux in a nonfunctioning kidney detected by 99mTc-DTPA study.

Authors:  Ebru Orsal; Bedri Seven; Irmak Durur Subasi; Arif Kursad Ayan; Zeynep Akkan
Journal:  Jpn J Radiol       Date:  2013-11-01       Impact factor: 2.374

Review 2.  Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?

Authors:  Fabrizio Presicce; Cosimo De Nunzio; Andrea Tubaro
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

3.  The value of respective urodynamic parameters for evaluating the occurrence of complications linked to benign prostatic enlargement.

Authors:  Xingliang Yang; Kai Wang; Jiang Zhao; Wei Yu; Longkun Li
Journal:  Int Urol Nephrol       Date:  2014-05-09       Impact factor: 2.370

Review 4.  Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.

Authors:  Fabrizio Presicce; Cosimo De Nunzio; Andrea Tubaro
Journal:  Curr Urol Rep       Date:  2018-07-09       Impact factor: 3.092

5.  MRI-based method for lower urinary tract dysfunction in adult male mice.

Authors:  Dalton T McLean; David R Rutkowski; Teresa Liu; Diego Hernando; William A Ricke; Alejandro Roldán-Alzate
Journal:  Am J Clin Exp Urol       Date:  2019-06-15

Review 6.  Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.

Authors:  Benjamin N Breyer; Aruna V Sarma
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

7.  Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

Authors:  Tristan M Nicholson; Emily A Ricke; Paul C Marker; Joseph M Miano; Robert D Mayer; Barry G Timms; Frederick S vom Saal; Ronald W Wood; William A Ricke
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

Review 8.  Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article.

Authors:  Ahmed Higazy; Dana Osman; Tarek Osman
Journal:  Int Urol Nephrol       Date:  2021-05-01       Impact factor: 2.370

9.  Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction.

Authors:  Nikesh Thiruchelvam
Journal:  Indian J Urol       Date:  2014-04

10.  Maximum Urine Flow Rate of Less than 15ml/Sec Increasing Risk of Urine Retention and Prostate Surgery among Patients with Alpha-1 Blockers: A 10-Year Follow Up Study.

Authors:  Hsin-Ho Liu; Tsung-Hsun Tsai; Shang-Sen Lee; Yu-Hung Kuo; Tengfu Hsieh
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.